Filip Van den Wyngaert joins TargED as Vice President Asset Management

We are proud to announce the appointment of Filip Van den Wyngaert as our Vice President Asset Management. Filip brings over 20 years of international experience in biotech and pharma, with a strong track record of driving assets from development to commercialization across multiple therapeutic areas, including rare diseases, hematology, and oncology.

Most recently, Filip led the Rare Disease business for Sanofi in the DACH region, achieving strong market growth, and previously played a pivotal role in the global success of Cablivi at Ablynx. His deep expertise will be instrumental as we advance our lead program into late-stage development and beyond.